Tag: GreenStar Biosciences - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

GreenStar Biosciences Announces New Provisional Patent Application

Post published:September 14, 2020
Post category:Press Release

GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

Post published:July 23, 2020
Post category:Press Release

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

Post published:July 21, 2020
Post category:Press Release

GreenStar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.

Post published:June 16, 2020
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Psychedelic Stocks and Companies
News & Interviews
Psychedelic Sector Jobs
Data Bank

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Psychedelic Sector Overview

Explore the Psychedelic Sector Landscape visually using our new tool.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin, MDMA and DMT.

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

How to Buy Psychedelic Stocks

Looking to invest in psychedelics? This handy guide explains how to buy stocks and shares outside of Canada.